Tailored titration for flexible and accurate dosing1
Designed for Children
Sialanar® (400mcg/ml glycopyrronium bromide equivalent to 320mcg/ml glycopyrronium) is licensed for the symptomatic treatment of severe sialorrhoea in children and adolescents aged 3 years and older with chronic neurological disorders.1
See the SALIVA Trial - The first and only double-blind, randomised, placebo controlled study in sialorrhoea, that has
investigated efficacy, tolerability and quality of life.2
Sialanar is Designed for Children
60% less volume vs. 1mg/5ml glycopyrronium bromide oral solutions, helping to improve patient acceptability1,3-7
Minimal excipients to reduce toxicity risk - sugar, alcohol and sorbitol free1,8,9
Use the links below to explore
-
About Sialanar®
Sialanar® is designed for children, learn more about its features and why they make a difference. Find out more
-
Dosing and Titration
Head to this section to find out more about the dosing and titration schedule for Sialanar®. Find out more
-
Clinical Evidence
The SALIVA trial demonstrated Sialanar® significantly improves drooling and its impact on quality of life, with good tolerability vs placebo.2 Find out more
-
Resources
Visit the resources section to find product support materials for patients/carers and educational resources for healthcare professionals. Find out more
-
Why treat drooling?
Did you know one population study found pneumonia is responsible for 39% of deaths in children with Cerebral Palsy.10 Find out more
Sign up for Proveca Education Events
Proveca run educational sessions on a regular basis covering a variety of topics, register here to be the first to know what’s coming up or head to our resources section to catch up on previous sessions.
